 Amgen Inc. NASDAQ:AMGN World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease Conference Call December 5, 2022 8:00 AM ET Company Participants David Reese - Executive Vice President, Research and Development Narimon Honarpour - Vice President, Clinical Development Conference Call Participants Umer Raffat - Evercore Matthew Harrison - Morgan Stanley Michael Yee - Jefferies Jay Olson - Oppenheimer Salveen Richter - Goldman Sachs Evan Seigerman - BMO Capital Geoff Meacham - Bank of America Colin Bristow - UBS Mohit Bansal - Wells Fargo Michael Schmidt - Guggenheim Partners David Risinger - SVB Securities Chris Schott - JPMorgan Chase Matt Phipps - William Blair Trung Huynh - Credit Suisse Colin Bristow - UBS Operator Hello and welcome. My name is Alex and I will be your conference facilitator today for the Amgen Analyst and Investor Conference Call from the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease Conference. 